We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOTL icon
51
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.99B
$3.71M 0.33%
92,620
+289
+0.3% +$11.5K
GEM icon
52
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.75B
$3.59M 0.32%
114,568
-1,576
-1% -$48K
OMFL icon
53
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.83B
$3.23M 0.28%
58,434
– –
VXUS icon
54
Vanguard Total International Stock ETF
VXUS
$163B
$3.17M 0.28%
52,605
+174
+0.3% +$10.1K
NVO
55
Novo Nordisk
NVO
$202B
$3.02M 0.27%
23,542
+2,283
+11% +$272K
NMRA icon
56
Neumora Therapeutics
NMRA
$261M
$2.82M 0.25%
+204,987
New +$3.31M
TSLA icon
57
Tesla
TSLA
$1.38T
$2.74M 0.24%
15,596
+8,281
+113% +$1.62M
LLY icon
58
Eli Lilly
LLY
$1.05T
$2.65M 0.23%
3,407
+579
+20% +$412K
ORCL icon
59
Oracle
ORCL
$435B
$2.64M 0.23%
21,027
+703
+3% +$80.5K
GOOG icon
60
Alphabet (Google) Class C
GOOG
$4.19T
$2.34M 0.21%
15,372
-1,373
-8% -$198K
META icon
61
Meta Platforms (Facebook)
META
$1.47T
$2.15M 0.19%
4,436
+1,725
+64% +$769K
AVIV icon
62
Avantis International Large Cap Value ETF
AVIV
$2.11B
$2M 0.18%
36,962
-4,102
-10% -$211K
XLU icon
63
State Street Utilities Select Sector SPDR ETF
XLU
$21.9B
$1.96M 0.17%
59,602
-1,114
-2% -$34.8K
AVES icon
64
Avantis Emerging Markets Value ETF
AVES
$1.54B
$1.92M 0.17%
40,559
+1,087
+3% +$50K
SCHA icon
65
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$1.89M 0.17%
76,718
+2
+0% +$47
HD icon
66
Home Depot
HD
$329B
$1.84M 0.16%
4,789
+548
+13% +$200K
VRTX icon
67
Vertex Pharmaceuticals
VRTX
$137B
$1.81M 0.16%
4,332
+141
+3% +$59.6K
XLB icon
68
State Street Materials Select Sector SPDR ETF
XLB
$8.81B
$1.81M 0.16%
38,868
-578
-1% -$24.9K
VO icon
69
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$1.8M 0.16%
28,808
-2,232
-7% -$132K
VOO icon
70
Vanguard S&P 500 ETF
VOO
$1.03T
$1.76M 0.16%
3,669
-103
-3% -$47.1K
BDX icon
71
Becton Dickinson
BDX
$51.6B
$1.74M 0.15%
7,039
+149
+2% +$35.7K
NFLX icon
72
Netflix
NFLX
$340B
$1.71M 0.15%
28,140
+2,910
+12% +$164K
HOMB icon
73
Home BancShares
HOMB
$5.93B
$1.71M 0.15%
69,513
-67,720
-49% -$1.61M
AVLV icon
74
Avantis US Large Cap Value ETF
AVLV
$19B
$1.7M 0.15%
26,497
-9,728
-27% -$583K
VNQ icon
75
Vanguard Real Estate ETF
VNQ
$38.6B
$1.68M 0.15%
19,370
-381
-2% -$32.6K
1 2
3
4 5

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.